Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Bing Ma

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 7, 2013
[Pulmonary lymphoma with hematogenous disseminated pulmonary tuberculosis: a case report]Hong-bing Ma, Xiao Shuai, Ting Liu
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 20, 2013
[Complex hemolytic anemia in one patient]Hong-bing Ma, Cheng-qi Deng, Ting Liu
International Journal of Hematology|October 1, 2010
A case report of acute lymphoblastic leukemia complicated by lactic acidosisHong Chang, Xiao Shuai, Hong-Bing Ma, et al.
Oncology Letters|November 25, 2021
Tanshinone IIA potentiates the efficacy of imatinib by regulating the AKT-MDM2-P53 signaling pathway in Philadelphia chromosome-positive acute lymphoblastic leukemiaYong Guo, Fang-Fang Wang, Bing Xiang, et al.
World Journal of Gastroenterology|January 14, 2014
Apoptotic pathway induced by diallyl trisulfide in pancreatic cancer cellsHong-Bing Ma, Shan Huang, Xiao-Ran Yin, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 7, 2008
[Effect of different patterns activation forms of CD40 on cloning of CD40 mutant and its proliferation and phenotype in RPMI8226 cell line]Lu Zheng, Hong-Bing Ma, Chun-Jian Qi, et al.
Japanese Journal of Clinical Oncology|November 23, 2014
Prospective, open, multicentre Phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and cisplatin for esophageal carcinomaHong-Bing Ma, Zheng-Li Di, Jiao Wen, et al.
International Journal of Hematology|October 25, 2011
Successful treatment of mast cell sarcoma of the uterus with imatinibHong Bing Ma, Xia Xu, Wei Ping Liu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|January 1, 2025
[Clinical Features and Prognosis of Patients with Primary Extranodal Diffuse Large B-Cell Lymphoma]Si Yi, Xia Li, Huan Tao, et al.
The Biochemical Journal|October 20, 2017
Nutlin-3 plus tanshinone IIA exhibits synergetic anti-leukemia effect with imatinib by reactivating p53 and inhibiting the AKT/mTOR pathway in Ph+ ALLYong Guo, Yi Li, Bing Xiang, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 7, 2013
[Pulmonary lymphoma with hematogenous disseminated pulmonary tuberculosis: a case report]Hong-bing Ma, Xiao Shuai, Ting Liu
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 20, 2013
[Complex hemolytic anemia in one patient]Hong-bing Ma, Cheng-qi Deng, Ting Liu
International Journal of Hematology|October 1, 2010
A case report of acute lymphoblastic leukemia complicated by lactic acidosisHong Chang, Xiao Shuai, Hong-Bing Ma, et al.
Oncology Letters|November 25, 2021
Tanshinone IIA potentiates the efficacy of imatinib by regulating the AKT-MDM2-P53 signaling pathway in Philadelphia chromosome-positive acute lymphoblastic leukemiaYong Guo, Fang-Fang Wang, Bing Xiang, et al.
World Journal of Gastroenterology|January 14, 2014
Apoptotic pathway induced by diallyl trisulfide in pancreatic cancer cellsHong-Bing Ma, Shan Huang, Xiao-Ran Yin, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 7, 2008
[Effect of different patterns activation forms of CD40 on cloning of CD40 mutant and its proliferation and phenotype in RPMI8226 cell line]Lu Zheng, Hong-Bing Ma, Chun-Jian Qi, et al.
Japanese Journal of Clinical Oncology|November 23, 2014
Prospective, open, multicentre Phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and cisplatin for esophageal carcinomaHong-Bing Ma, Zheng-Li Di, Jiao Wen, et al.
International Journal of Hematology|October 25, 2011
Successful treatment of mast cell sarcoma of the uterus with imatinibHong Bing Ma, Xia Xu, Wei Ping Liu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|January 1, 2025
[Clinical Features and Prognosis of Patients with Primary Extranodal Diffuse Large B-Cell Lymphoma]Si Yi, Xia Li, Huan Tao, et al.
The Biochemical Journal|October 20, 2017
Nutlin-3 plus tanshinone IIA exhibits synergetic anti-leukemia effect with imatinib by reactivating p53 and inhibiting the AKT/mTOR pathway in Ph+ ALLYong Guo, Yi Li, Bing Xiang, et al.
Pageof 5